Search Results - "Larrabee, Lance"

Ligand-Blocking and Membrane-Proximal Domain Targeting Anti-OX40 Antibodies Mediate Potent T Cell-Stimulatory and Anti-Tumor Activity by Zhang, Pamela, Tu, Guang Huan, Wei, Jie, Santiago, Pamela, Larrabee, Lance R, Liao-Chan, Sindy, Mistry, Tina, Chu, Matthew Ling-Hon, Sai, Tao, Lindquist, Kevin, Long, Hua, Chaparro-Riggers, Javier, Salek-Ardakani, Shahram, Yeung, Yik Andy

“…Agonistic antibodies targeting the tumor necrosis factor (TNF) superfamily of co-stimulatory receptors (TNFRSF) are progressing through various stages of…”
Get full text

CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody by Melero, Cristina, Budiardjo, S Jimmy, Daruwalla, Anahita, Larrabee, Lance, Ganichkin, Oleg, Heiler, Alexander J, Fenaux, Jill, Chung, Ben, Fuh, Germaine, Huang, Yao-Ming

“…Human CD200R1 (hCD200R1), an immune inhibitory receptor expressed predominantly on T cells and myeloid cells, was identified as a promising immuno-oncology…”
Get full text

Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension by Zhang, Shan-Shan, Larrabee, Lance, Chang, Andrew H., Desai, Sapna, Sloan, Lisa, Wang, Xin, Wu, Yixuan, Parvez, Nazia, Amaratunga, Karen, Hartman, Allison C., Whitnall, Abby, Mason, Joseph, Barton, Nicholas P., Chu, Audrey Y., Davitte, Jonathan M., Csakai, Adam J., Tibbetts, Caitlin Vestal, Tolbert, Audrey E., O’Keefe, Heather, Polanco, Jessie, Foley, Joseph, Kmett, Casey, Kehler, Jonathan, Kozejova, Gabriela, Wang, Feng, Mayer, Andrew P., Koenig, Patrick, Foletti, Davide, Pitts, Steven J., Schnackenberg, Christine G.

“…Hypertension remains a leading cause of cardiovascular and kidney diseases. Failure to control blood pressure with ≥ 3 medications or control requiring ≥ 4…”
Get full text

An Engineered Mouse Model That Generates a Diverse Repertoire of Endogenous, High-Affinity Common Light Chain Antibodies by Rong, Yinghui, Chen, I-Ling, Larrabee, Lance, Sawant, Manali S, Fuh, Germaine, Koenig, Patrick

“…Bispecific antibodies have gained increasing popularity as therapeutics as they enable novel activities that cannot be achieved with monospecific antibodies…”
Get full text